Understanding Congenital Primary Aphakia: A Guide for Parents
At a Glance
Congenital Primary Aphakia (CPA) is a rare genetic condition where a baby is born without an eye lens, often due to a FOXE3 mutation. While it limits vision and requires lifelong monitoring for glaucoma, early intervention and low-vision aids can help maximize your child's development.
Learning that your child has Congenital Primary Aphakia (CPA) can be an overwhelming and isolating experience. This diagnosis means your child was born without the natural lens of the eye [1]. It is a very rare condition, and it is natural to feel a profound sense of shock, grief, or fear about the future [2][3].
While the road ahead involves significant medical challenges, understanding the facts can help you move from a place of uncertainty to a position of informed advocacy for your child.
Understanding the Diagnosis
The word aphakia means “without a lens.” In Congenital Primary Aphakia, the lens never formed while your child was developing in the womb [1]. This happens because of a failure in “lens induction”—the specific signal that tells the body to start growing a lens from the surface of the eye [1].
This is different from other types of aphakia where a lens might have formed but was then damaged or removed. Because the lens is essential for the overall growth of the eye, its absence is often accompanied by other developmental issues, such as:
- Microphthalmia: The eye is smaller than average [4].
- Corneal Opacity: The “window” of the eye (the cornea) may be cloudy or scarred [5].
- Anterior Segment Dysgenesis: Other structures in the front of the eye did not develop correctly [4].
Stabilizing Facts for Parents
When faced with a rare diagnosis, these core facts can provide a foundation for your next steps:
- It is not your fault: CPA is almost always the result of a genetic mutation, most commonly in a gene called FOXE3, which acts like a master switch for eye development [6][1]. It is a biological event that happened long before your child was born.
- Early intervention is your best tool: While the visual prognosis (the outlook for clear sight) is often limited, your child can still learn to navigate and interact with the world [7]. Starting “Early Intervention” services immediately can support their overall development through sensory and motor therapies [8].
- You are the lead of a multidisciplinary team: You do not have to manage this alone. Your child’s care will involve a team of specialists, including pediatric ophthalmologists, geneticists, and low-vision experts [9].
Managing Potential Complications
Because the eye did not form completely, it may have trouble regulating its internal environment. Two major areas your doctors will monitor are:
- Secondary Glaucoma: This occurs when the fluid pressure inside the eye becomes too high [5]. It requires lifelong monitoring to prevent further damage to the eye structures.
- Hypotony and Phthisis: Sometimes, the eye pressure is too low (hypotony), which can cause the eye to shrink (phthisis) [7]. This happens because the ciliary body (the part of the eye that produces fluid) may be underdeveloped [5].
Research: What We Know and What We Expect
Research has made significant strides in identifying the genetic causes of CPA. We know that FOXE3 mutations are a primary cause, though other genes like PXDN may also be involved [10][4]. Genetic testing can often confirm the diagnosis and help your family understand the risk of recurrence in future pregnancies [10].
However, there are still unknowns. Because the condition is so rare, there is no single “standard” surgical approach that works for every child. Surgery in CPA is complex and carries a high risk of complications like eye shrinkage [7]. Your medical team will carefully weigh whether surgery or a more conservative approach using low-vision aids is the safest path forward for your child [5][7].
What to Expect in the First Year: Given the need to closely monitor eye pressure in a small infant, your child may frequently require Exams Under Anesthesia (EUAs) [11]. This allows the doctor to safely and accurately measure eye pressure and examine internal structures without causing pain or stress to the baby.
Empowering Your Journey
The goal of care is not always “perfect 20/20 vision,” but rather maximizing your child’s functional vision and quality of life [12]. This may involve:
- Low Vision Aids: Specialized tools and technology to help your child use the vision they have.
- Symptom Management: Using drops or procedures to keep eye pressure stable and comfortable.
- Peer Support: Connecting with other parents of children with rare eye conditions can significantly reduce the “caregiver burden” and provide emotional resilience [13][14]. Outreach to organizations like the National Federation of the Blind or specialized rare disease groups can be a vital lifeline.
Common questions in this guide
What causes congenital primary aphakia?
Why does my child need exams under anesthesia (EUAs)?
What are the main complications of congenital primary aphakia?
Will my child need surgery for congenital primary aphakia?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is the condition affecting one or both of my child's eyes?
- 2.What is my child's current intraocular pressure, and are we seeing signs of glaucoma or ciliary body issues?
- 3.Can we perform a genetic panel (specifically looking at FOXE3 and PXDN) to confirm the diagnosis and understand the risk for future children?
- 4.What specific low vision services or early intervention programs can we start now to support my child's development?
- 5.What are the risks and benefits of surgical intervention versus a non-surgical approach in my child's specific case?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
CUGC for congenital primary aphakia.
Sarkar H, Moore W, Leroy BP, Moosajee M
European journal of human genetics : EJHG 2018; (26(8)):1234-1237 doi:10.1038/s41431-018-0171-x.
PMID: 29769628 - 2
Long-term life expectancy in severe traumatic brain injury: a systematic review.
DE Tanti A, Bruni S, Bonavita J, et al.
European journal of physical and rehabilitation medicine 2024; (60(5)):810-821 doi:10.23736/S1973-9087.24.08461-2.
PMID: 39291953 - 3
Changes in attitudes toward systemic lupus erythematosus and associated factors: a retrospective cross-sectional study from China.
Zhao M, Xie SW, Huang X, et al.
Frontiers in immunology 2026; (17()):1759777 doi:10.3389/fimmu.2026.1759777.
PMID: 41668744 - 4
Lack of FOXE3 coding mutation in a case of congenital aphakia.
Sano Y, Matsukane Y, Watanabe A, et al.
Ophthalmic genetics 2018; (39(1)):95-98 doi:10.1080/13816810.2017.1350722.
PMID: 28805541 - 5
Anterior segment alterations in congenital primary aphakia-a clinicopathologic report of five cases.
Chaurasia S, Jakati S, Ramappa M, et al.
Indian journal of ophthalmology 2020; (68(8)):1564-1568 doi:10.4103/ijo.IJO_2078_19.
PMID: 32709777 - 6
A zebrafish model of foxe3 deficiency demonstrates lens and eye defects with dysregulation of key genes involved in cataract formation in humans.
Krall M, Htun S, Anand D, et al.
Human genetics 2018; (137(4)):315-328 doi:10.1007/s00439-018-1884-1.
PMID: 29713869 - 7
Primary aphakia: clinical recognition is the key to diagnosis.
Kaushik S, Snehi S, Kaur S, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2022; (26(6)):298.e1-298.e5 doi:10.1016/j.jaapos.2022.07.012.
PMID: 36183996 - 8
Knowledge of Childhood Blindness and Associated Factors Among Parents or Guardians in Maksegnit Town, Northwest Ethiopia.
Assefa NL, Tolessa KG, Ferede AT
Clinical optometry 2020; (12()):175-182 doi:10.2147/OPTO.S275071.
PMID: 33117028 - 9
Effects of the Close Collaboration With Parents Intervention on the Quality of Family-Centered Care in NICUs.
Toivonen M, Lehtonen L, Ahlqvist-Björkroth S, Axelin A
Advances in neonatal care : official journal of the National Association of Neonatal Nurses 2023; (23(3)):281-289 doi:10.1097/ANC.0000000000000953.
PMID: 34596090 - 10
Novel prenatally diagnosed compound heterozygous PXDN variants in fetal congenital primary aphakia and blepharophimosis.
Chou WS, Shiao YM, Chen JS, et al.
Taiwanese journal of obstetrics & gynecology 2022; (61(3)):510-513 doi:10.1016/j.tjog.2022.03.019.
PMID: 35595447 - 11
Congenital primary aphakia.
Ernst J, Medsinge A, Scanga HL, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2022; (26(1)):4.e1-4.e5 doi:10.1016/j.jaapos.2021.09.008.
PMID: 35051625 - 12
Current and coming challenges in the management of the survivorship population.
Chow EJ, Ness KK, Armstrong GT, et al.
Seminars in oncology 2020; (47(1)):23-39 doi:10.1053/j.seminoncol.2020.02.007.
PMID: 32197774 - 13
[An open heart: experiences of the parents of children with congenital heart disease].
Páramo-Rodríguez L, Mas Pons R, Cavero-Carbonell C, et al.
Gaceta sanitaria 2015; (29(6)):445-50.
PMID: 26321623 - 14
Psychological interventions for enhancing resilience in parents of children with cancer: a systematic review and meta-analysis.
Luo YH, Xia W, He XL, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2021; (29(11)):7101-7110 doi:10.1007/s00520-021-06344-0.
PMID: 34131847
This page provides educational information about Congenital Primary Aphakia for parents and caregivers. Always consult your pediatric ophthalmologist or geneticist for medical advice regarding your child's specific case and treatment plan.
Get notified when new evidence is published on Congenital primary aphakia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.